by admin_63069 | May 30, 2023 | Related Topics
Expert oncologists briefly review the current treatment paradigm of metastatic castration-resistant prostate cancer (mCRPC).
by admin_63069 | May 29, 2023 | News You Can Use
Researchers examined the impact of deep learning–based AI software upon radiologists reviewing multiparametric MRI scans in the assessment of clinically significant prostate cancer.
by admin_63069 | May 26, 2023 | Related Topics
Kelly L. Stratton, MD, FACS, recaps several presentations on prostate cancer from the 2023 American Urological Association Annual Meeting in Chicago, Illinois.
by admin_63069 | May 25, 2023 | News You Can Use
A database analysis showed that zoledronic acid led to a 64% reduction in fracture risk among patients with metastatic hormone-sensitive prostate cancer.
by admin_63069 | May 23, 2023 | Related Topics
The importance of quality of life and multi-disciplinary care
